Market Definition for Patented Products: The Second Circuit Reinstates Regeneron v. Novartis
Mogin Rubin M&A
MARCH 21, 2024
Written by Jonathan Rubin, Partner and Co-Founder of MoginRubin LLP The Second Circuit U.S. Court of Appeals has reinstated an antitrust complaint brought by pharma firm, Regeneron Pharmaceuticals, Inc., against the Swiss pharmaceutical giant, Novartis Pharma AG, and outside fulfillment firm, Vetter Pharma International GmbH.
59 
Let's personalize your content